6-K Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 Q2 2021

Filing Information

Form Type	6-K
Accession Number	`0001213900-21-043781`
Period End Date	20210630
Filing Date	20210819
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	ea145716-6k_collplant_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 60 Cash Flow Statement 78 Stockholders Equity 33

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.48M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.33M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	10.26M	shares	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	6.96M	shares	Point-in-time
Short term cash deposits	`DepositsAssetsCurrent`	-	USD	Point-in-time
Short term cash deposits	`DepositsAssetsCurrent`	$30.07M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	10.26M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	6.96M	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$830.00K	USD	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$277.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$979.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$239.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Inventory	`InventoryNet`	$940.00K	USD	Point-in-time
Inventory	`InventoryNet`	$1.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$49.77M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$178.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$181.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.79M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.11M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.12M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$82.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$164.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.25M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.17M	USD	Point-in-time
Total assets	`Assets`	$10.84M	USD	Point-in-time
Total assets	`Assets`	$55.02M	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$698.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$798.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.94M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.58M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$440.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$651.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$207.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.39M	USD	Point-in-time
Derivatives liability	`DerivativeLiabilitiesNoncurrent`	$28.00K	USD	Point-in-time
Derivatives liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.65M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.95M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.65M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.98M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.58M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2021 and December 31, 2020; issued and outstanding: 10,258,129 and 6,963,838 ordinary shares as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$4.45M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of June 30, 2021 and December 31, 2020; issued and outstanding: 10,258,129 and 6,963,838 ordinary shares as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$2.93M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalAndWarrants`	$75.55M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalAndWarrants`	$111.91M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-65.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.03M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$50.65M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$5.78M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.09M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$49.44M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$7.27M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$55.02M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$10.84M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$1.43M	USD	2 Qtrs
Revenues	`Revenues`	$15.19M	USD	2 Qtrs
Revenues	`Revenues`	$823.00K	USD	1 Quarter
Revenues	`Revenues`	$691.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$429.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.22M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$1.31M	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	$748.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$13.88M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$262.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$75.00K	USD	1 Quarter
Gross Profit	`GrossProfit`	$209.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.53M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.81M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$1.42M	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.38M	USD	2 Qtrs
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$986.00K	USD	1 Quarter
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$2.02M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-3.62M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-1.91M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-3.06M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$6.96M	USD	2 Qtrs
Financial income	`FinancialIncome`	$9.00K	USD	1 Quarter
Financial income	`FinancialIncome`	$122.00K	USD	2 Qtrs
Financial income	`FinancialIncome`	$72.00K	USD	1 Quarter
Financial income	`FinancialIncome`	$26.00K	USD	2 Qtrs
Financial expenses	`FinancialExpenses`	$27.00K	USD	2 Qtrs
Financial expenses	`FinancialExpenses`	$2.00K	USD	1 Quarter
Financial expenses	`FinancialExpenses`	$8.00K	USD	1 Quarter
Financial expenses	`FinancialExpenses`	$6.00K	USD	2 Qtrs
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$65.00K	USD	1 Quarter
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$-28.00K	USD	2 Qtrs
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$-28.00K	USD	2 Qtrs
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$39.00K	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$123.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$48.00K	USD	2 Qtrs
Financial income (expenses), net	`FinancialExpensesNet`	$25.00K	USD	1 Quarter
Financial income (expenses), net	`FinancialExpensesNet`	$-58.00K	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$7.09M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-1.97M	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-3.04M	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-3.57M	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.52	USD	2 Qtrs
Basic net income (loss) per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$0.76	USD	2 Qtrs
Diluted net income (loss) per ordinary share (in Dollars per share)	`DilutedNetIncomelossPerOrdinaryShareinDollarsPerShare`	$-0.30	USD	1 Quarter
Diluted net income (loss) per ordinary share (in Dollars per share)	`DilutedNetIncomelossPerOrdinaryShareinDollarsPerShare`	$-0.52	USD	2 Qtrs
Diluted net income (loss) per ordinary share (in Dollars per share)	`DilutedNetIncomelossPerOrdinaryShareinDollarsPerShare`	$0.58	USD	2 Qtrs
Diluted net income (loss) per ordinary share (in Dollars per share)	`DilutedNetIncomelossPerOrdinaryShareinDollarsPerShare`	$-0.28	USD	1 Quarter
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.20M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.32M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.96M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.81M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingUsedInComputationOfBasicAndDilutedLossP`	10.20M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingUsedInComputationOfBasicAndDilutedLossP`	12.17M	shares	2 Qtrs
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingUsedInComputationOfBasicAndDilutedLossP`	6.96M	shares	1 Quarter
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares)	`WeightedAverageNumberOfSharesOutstandingUsedInComputationOfBasicAndDilutedLossP`	6.81M	shares	2 Qtrs

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Net cash provided by (used in) operations (see Appendix A)	`NetCashUsedInOperationsseeAppendixA`	$-7.74M	USD	2 Qtrs
Net cash provided by (used in) operations (see Appendix A)	`NetCashUsedInOperationsseeAppendixA`	$4.34M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.74M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.34M	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$82.00K	USD	2 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	-	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$365.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$246.00K	USD	2 Qtrs
Short term cash deposits	`ShortTermCashDeposits`	-	USD	2 Qtrs
Short term cash deposits	`ShortTermCashDeposits`	$30.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-246.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-30.45M	USD	2 Qtrs
Proceeds from issuance of shares and warrants, less issuance expenses	`ProceedsFromIssuanceOfWarrants`	$4.40M	USD	2 Qtrs
Proceeds from issuance of shares and warrants, less issuance expenses	`ProceedsFromIssuanceOfWarrants`	$32.74M	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromStockOptionsExercised`	$67.00K	USD	2 Qtrs
Exercise of options and warrants into shares	`ProceedsFromStockOptionsExercised`	$4.13M	USD	2 Qtrs
Loan paid	`RepaymentsOfDebt`	$12.00K	USD	2 Qtrs
Loan paid	`RepaymentsOfDebt`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.46M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$36.87M	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$14.16M	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-134.00K	USD	2 Qtrs
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.68M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-13.00K	USD	2 Qtrs
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.68M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Income (loss)	`ProfitLoss`	$-7.09M	USD	2 Qtrs
Income (loss)	`ProfitLoss`	$3.57M	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$327.00K	USD	2 Qtrs
Depreciation	`DepreciationAndAmortization`	$352.00K	USD	2 Qtrs
Gains from Short term cash deposits	`ProceedsFromShortTermDebt`	$-74.00K	USD	2 Qtrs
Gains from Short term cash deposits	`ProceedsFromShortTermDebt`	-	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$954.00K	USD	2 Qtrs
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$794.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-13.00K	USD	2 Qtrs
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$14.00K	USD	2 Qtrs
Financial income related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-28.00K	USD	2 Qtrs
Financial income related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-26.00K	USD	2 Qtrs
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	$32.00K	USD	2 Qtrs
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	$84.00K	USD	2 Qtrs
Total net cash used in operations	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-2.52M	USD	2 Qtrs
Total net cash used in operations	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$8.22M	USD	2 Qtrs
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-553.00K	USD	2 Qtrs
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$242.00K	USD	2 Qtrs
Decrease in inventory	`IncreaseDecreaseInInventories`	$-322.00K	USD	2 Qtrs
Decrease in inventory	`IncreaseDecreaseInInventories`	$-158.00K	USD	2 Qtrs
Increase in other receivables	`IncreaseDecreaseInOtherReceivables`	$740.00K	USD	2 Qtrs
Increase in other receivables	`IncreaseDecreaseInOtherReceivables`	$480.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-274.00K	USD	2 Qtrs
Decrease in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-100.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-309.00K	USD	2 Qtrs
Decrease in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-337.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-645.00K	USD	2 Qtrs
Decrease in deferred revenues	`IncreaseDecreaseInDeferredRevenue`	$-207.00K	USD	2 Qtrs
Total changes in operating asset and liability	`IncreaseDecreaseInOperatingCapital`	$1.82M	USD	2 Qtrs
Total changes in operating asset and liability	`IncreaseDecreaseInOperatingCapital`	$481.00K	USD	2 Qtrs
Net cash provided by (used in) operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-4.34M	USD	2 Qtrs
Net cash provided by (used in) operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$7.74M	USD	2 Qtrs
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$137.00K	USD	2 Qtrs
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$23.00K	USD	2 Qtrs
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$184.00K	USD	2 Qtrs
Issuance costs, not yet paid	`ProceedsFromIssuanceCosts`	-	USD	2 Qtrs
Issuance costs, not yet paid	`ProceedsFromIssuanceCosts`	$50.00K	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalent`	$17.48M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalent`	$3.67M	USD	2 Qtrs
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$190.00K	USD	2 Qtrs
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$179.00K	USD	2 Qtrs
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.85M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.68M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$50.00K	USD	2 Qtrs
Ordinary shares and warrants, net of issuance costs	`OrdinarySharesAndWarrantsNetOfIssuanceCosts`	$3.20M	USD	2 Qtrs
Exercise of warrants, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$17.00K	USD	1 Quarter
Exercise of warrants, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$51.00K	USD	2 Qtrs
Balance	`StockholdersEquity`	$50.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.78M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.27M	USD	Point-in-time
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$32.79M	USD	2 Qtrs
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$4.40M	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$110.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$67.00K	USD	2 Qtrs
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.00K	USD	1 Quarter
Exercise of warrants, net of issuance costs	`StockIssuedDuringPeriodValueOther`	$4.02M	USD	2 Qtrs
Exercise of warrants, net of issuance costs	`StockIssuedDuringPeriodValueOther`	$1.35M	USD	1 Quarter
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$954.00K	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$794.00K	USD	2 Qtrs
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$469.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$477.00K	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$7.09M	USD	2 Qtrs
Comprehensive loss	`OtherComprehensiveIncomeLossTax`	$-3.04M	USD	1 Quarter
Comprehensive loss	`OtherComprehensiveIncomeLossTax`	$-1.97M	USD	1 Quarter
Comprehensive loss	`OtherComprehensiveIncomeLossTax`	$-3.57M	USD	2 Qtrs
Balance	`StockholdersEquity`	$50.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.78M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.27M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.